Pradžia › Reumatoidinis artritas › Texas › Houston

Reumatoidinis artritas klinikiniai tyrimai Houston, TX

11 tyrimai dėl Reumatoidinis artritas ieško dalyvių vietose Houston ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

RA-PRO PRAGMATIC TRIAL

Renkami dalyviai3 fazė

Baylor University, Houston

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT04692493

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Renkami dalyviai1 fazė

UT MD Anderson Cancer Center, Houston

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Renkami dalyviai2 fazė

Accurate Clinical Research - Houston /ID# 272271, Houston
Private Practice - Dr. Laila A. Hassan /ID# 272297, Houston
Care & Cure Clinic /ID# 281684, Houston

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT06972446

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

Renkami dalyviai2 fazė

Accurate Clinical Management, Houston

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT07137598

An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis

Renkami dalyviai2 fazė

Accurate Clinical Management LLC, Houston

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT07620392

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Renkami dalyviai1/2 fazė

Nkarta Investigational Site, Houston

Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06733935

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Renkami dalyviai2 fazė

Artiva Investigational Site Bellaire, Bellaire · už 7 mylių

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-31 · NCT06991114

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

Renkami dalyviai2 fazė

Research Site, Houston
Research Site, Houston

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-24 · NCT07276581

R-2487 in Patients With Rheumatoid Arthritis

Renkami dalyviai1 fazė

Prolato Clinical Research Center, Houston

Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-06-12 · NCT05961592

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Renkami dalyviaiStebimasis tyrimas

M D Anderson Cancer Center, Houston

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-20 · NCT04751396

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Renkami dalyviaiStebimasis tyrimas

The University of Texas MD Anderson Cancer Center, Houston

Amžius nuo 18 iki 71 · Visoms lytims · Atnaujinta 2026-04-16 · NCT07123038

Reumatoidinis artritas tyrimai kituose miestuose

Kiti tyrimai Houston

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.